Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
bullish
Mega Lifesciences
Watchlist
MEGA: Supplement Maker Spreads Healthy Message in Booming Region
Equity Bottom-Up
464 Views
12 Sep 2018 01:47
Broker
We initiate coverage on MEGA with a BUY rating and based on a target price of Bt43, which is derived from the DCF methodology (WACC 12.5% and...
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 7-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Equity Bottom-Up
Event-Driven
India
South Korea
China
Japan
Unpaywalled Insights
Index Rebalance
Asia Event-Driven
Equity Derivatives
Trending Insights
More »
Zhejiang Sanhua Intelligent Controls (2050 HK): Big Raise Supported by Cornerstones
Singapore Airlines - Confluence of events (SIA SP, CP SGD7.03, HOLD, TP SGD6.85, Airlines)
Key Markets Tactical Outlooks After Israel Strike on Iran
Wuxi Biologics Placement - Smaller Deal than Previous as Last Didn’t Do Well, Overhang Remain
Fengxiang (9977 HK): PAG Invites Dissent After Scrapping Scrip Alternative
Top Unpaywalled Insights
More »
[IO Technicals 2025/24] Downward Momentum Lingers
China A-Share Consumer Staples: An Analysis of the Opportunities Ahead
Bearishness Persist in Soybeans Despite Rebound Hopes
Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
[IO Technicals 2025/23] Bearish Momentum Persists
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
VIBHA: Large Hospital Chain at the Cheapest Price
31 Oct 2018
SUTHA: Growing Quick Lime Via Acquisitions & Expansion
18 Sep 2018
Consumption Diary: What in the EV World Is Driving NIO? Plus @Smartkarma - Vitamins, Retail & More
17 Sep 2018
Little Thai-Coons of 2018 (Part 2): The New Industrialists
04 Jul 2018
MEGA (MEGA TB): ASEAN and Africa Continue to Offer Mega Opportunities
27 Mar 2018
NTV: Health Provider Leads Care in Northern Metro Bangkok
13 Feb 2018
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x